Impact of high on-treatment platelet reactivity after angioplasty in patients with critical limb ischemia.
Sign Up to like & getrecommendations! Published in 2021 at "Vascular pharmacology"
DOI: 10.1016/j.vph.2021.106925
Abstract: OBJECTIVES Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel is standard of care in patients with peripheral artery disease (PAD) after percutaneous transluminal angioplasty (PTA). However, high on treatment platelet reactivity (HTPR) to DAPT is… read more here.
Keywords: patients critical; high treatment; limb; htpr ... See more keywords
Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients
Sign Up to like & getrecommendations! Published in 2020 at "Bioscience Reports"
DOI: 10.1042/bsr20201346
Abstract: Abstract High-on treatment platelet reactivity (HTPR) leads to more prevalence of thrombotic event in patients undergoing percutaneous coronary interventions (PCI). Dual antiplatelet therapy with aspirin in addition to one P2Y12 inhibitor is commonly administrated to… read more here.
Keywords: high treatment; treatment; platelet reactivity; platelet mapping ... See more keywords
Impact of high on-treatment platelet reactivity after angioplasty in patients with peripheral arterial disease
Sign Up to like & getrecommendations! Published in 2020 at "Platelets"
DOI: 10.1080/09537104.2020.1742314
Abstract: Abstract Objective: High on-treatment platelet reactivity (HTPR) to dual antiplatelet therapy (DAPT) predicts adverse events in coronary artery disease patients. In peripheral artery disease (PAD) patients, data concerning the clinical impact of HTPR are limited.… read more here.
Keywords: high treatment; treatment; disease; platelet reactivity ... See more keywords
Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000019472
Abstract: Abstract High on-treatment platelet reactivity (HTPR) was suggested to be better correlated with recurrent ischemic events as compared with gene polymorphism, whereas most of the results were from white populations with acute coronary disease. The… read more here.
Keywords: ischemic stroke; gene polymorphism; stroke; high treatment ... See more keywords
Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of haematology"
DOI: 10.1111/bjh.17847
Abstract: High on-treatment platelet reactivity (HOPR) is associated with increased risk of cardiovascular events in patients undergoing percutaneous coronary intervention (PCI). We randomised post-PCI patients with HOPR after 5 days of standard dual antiplatelet therapy (DAPT) to… read more here.
Keywords: high treatment; antiplatelet therapy; therapy; treatment platelet ... See more keywords
Exploring the ability of self-report measures to identify risk of high treatment burden in chronic disease patients: a cross-sectional study
Sign Up to like & getrecommendations! Published in 2022 at "BMC Public Health"
DOI: 10.1186/s12889-022-12579-1
Abstract: Background Effective self-management of chronic health conditions is key to avoiding disease escalation and poor health outcomes, but self-management abilities vary. Adequate patient capacity, in terms of abilities and resources, is needed to effectively manage… read more here.
Keywords: high treatment; capacity; treatment burden; treatment ... See more keywords
High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction
Sign Up to like & getrecommendations! Published in 2017 at "Anatolian Journal of Cardiology"
DOI: 10.14744/anatoljcardiol.2016.7042
Abstract: Objective: The aim of the present study was to assess long-term prognostic value of high on-treatment platelet reactivity (HTPR) in patients after acute myocardial infarction (MI) and its association with possible risk factors. Methods: This… read more here.
Keywords: risk; high treatment; patients acute; year ... See more keywords